Terms: = Pancreatic cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Prognosis
45 results:
1. Current status of Complementary and Alternative Medicine Interventions in the Management of pancreatic cancer - An Overview.
Tarasiuk A; Mirocha G; Fichna J
Curr Treat Options Oncol; 2023 Dec; 24(12):1852-1869. PubMed ID: 38079061
[TBL] [Abstract] [Full Text] [Related]
2. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-ap1 axis.
Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
[TBL] [Abstract] [Full Text] [Related]
3. Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk.
Qin H; Chen J; Bouchekioua-Bouzaghou K; Meng YM; Griera JB; Jiang X; Kong X; Wang M; Xu Q; Wong PP
J Transl Med; 2023 Oct; 21(1):702. PubMed ID: 37814317
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
[TBL] [Abstract] [Full Text] [Related]
5. TMPOP2 Inhibition Suppresses pancreatic cancer Cell Migration and Development by Repressing The JNK/STAT3 Pathway.
Liang J; Cao H; Wang G; Wei L; Dong L; Chen G; Li Q; Zhu D
Adv Biol (Weinh); 2023 Dec; 7(12):e2300113. PubMed ID: 37469237
[TBL] [Abstract] [Full Text] [Related]
6. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/Yap1/c-jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
7. PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma.
He X; Xu J; Niu N; Xu G; Zhu H; Liu Z; Mou Y; Qian Z; Wang H; Hu J; Ma T; Ma J; Tao H
Clin Transl Med; 2022 Oct; 12(10):e1062. PubMed ID: 36178086
[TBL] [Abstract] [Full Text] [Related]
8. Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/jun-mediated signaling pathway.
Miao H; Geng Y; Li Y; Tang S; Feng F; Li W; Li Y; Liu L; Zhang R; Qiu S; Wu Y; Wang Z; Wang Z; Shao Z; Liu K; Zou L; Yang M; Zhao Y; Chen C; Li Z; Zhang D; Peng P; Qiang X; Wu F; He Y; Chen L; Xiang D; Jiang X; Li M; Liu Y; Liu Y
Cell Oncol (Dordr); 2022 Aug; 45(4):689-708. PubMed ID: 35870050
[TBL] [Abstract] [Full Text] [Related]
9. Gene Differential Expression and Interaction Networks Illustrate the Biomarkers and Molecular Biological Mechanisms of Unsaponifiable Matter in Kanglaite Injection for pancreatic Ductal Adenocarcinoma.
Xu B; Dan W; Zhang X; Wang H; Cao L; Li S; Li J
Biomed Res Int; 2022; 2022():6229462. PubMed ID: 35707377
[TBL] [Abstract] [Full Text] [Related]
10. ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway.
Du T; Zhang K; Zhang Z; Guo A; Yu G; Xu Y
Braz J Med Biol Res; 2022; 55():e11989. PubMed ID: 35584452
[TBL] [Abstract] [Full Text] [Related]
11. TNF-α-producing macrophages determine subtype identity and prognosis via ap1 enhancer reprogramming in pancreatic cancer.
Tu M; Klein L; Espinet E; Georgomanolis T; Wegwitz F; Li X; Urbach L; Danieli-Mackay A; Küffer S; Bojarczuk K; Mizi A; Günesdogan U; Chapuy B; Gu Z; Neesse A; Kishore U; Ströbel P; Hessmann E; Hahn SA; Trumpp A; Papantonis A; Ellenrieder V; Singh SK
Nat Cancer; 2021 Nov; 2(11):1185-1203. PubMed ID: 35122059
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic significance of SHP2 (PTPN11) expression in solid tumors: A meta-analysis.
Zhou J; Guo H; Zhang Y; Liu H; Dou Q
PLoS One; 2022; 17(1):e0262931. PubMed ID: 35061863
[TBL] [Abstract] [Full Text] [Related]
13. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
Liu XD; Zhang ZW; Wu HW; Liang ZY
Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
[TBL] [Abstract] [Full Text] [Related]
14. Effect of miR-184 on Proliferation and Apoptosis of pancreatic Ductal Adenocarcinoma and Its Mechanism.
Li S; Li H; Ge W; Song K; Yuan C; Yin R
Technol Cancer Res Treat; 2020; 19():1533033820943237. PubMed ID: 32914707
[TBL] [Abstract] [Full Text] [Related]
15. Relationship between SDC1 and cadherin signalling activation in cancer.
Liao S; Liu C; Zhu G; Wang K; Yang Y; Wang C
Pathol Res Pract; 2020 Jan; 216(1):152756. PubMed ID: 31810587
[TBL] [Abstract] [Full Text] [Related]
16. pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8.
Wang HC; Lin YL; Hsu CC; Chao YJ; Hou YC; Chiu TJ; Huang PH; Tang MJ; Chen LT; Shan YS
Theranostics; 2019; 9(24):7168-7183. PubMed ID: 31695760
[No Abstract] [Full Text] [Related]
17. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile.
Cao L; Hong J; Wang Y; Yu J; Ma R; Li J; Wu J; Zheng S
Medicine (Baltimore); 2019 Jul; 98(28):e16245. PubMed ID: 31305404
[TBL] [Abstract] [Full Text] [Related]
18. Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talk with primary pancreatic stellate cells using bioinformatics analysis.
Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
Neoplasma; 2019 Sep; 66(5):681-693. PubMed ID: 31169017
[TBL] [Abstract] [Full Text] [Related]
19. NOX4, a new genetic target for anti-cancer therapy in digestive system cancer.
Tang CT; Gao YJ; Ge ZZ
J Dig Dis; 2018 Oct; 19(10):578-585. PubMed ID: 30058122
[TBL] [Abstract] [Full Text] [Related]
20. Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC.
Liu Y; Zhang X; Yang B; Zhuang H; Guo H; Wei W; Li Y; Chen R; Li Y; Zhang N
Cancer Res; 2018 May; 78(9):2219-2232. PubMed ID: 29330146
[TBL] [Abstract] [Full Text] [Related]
[Next]
